168 results on '"Mahmoud, Sara H."'
Search Results
2. Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle
3. Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies
4. In vitro antiviral effect of cinnamon oil, Moringa oleifera extract, Manuka honey, and Nigella sativa oil against SARS-CoV-2 compared to remdesivir
5. Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses
6. Potential role of PIM1 inhibition in the treatment of SARS-CoV-2 infection
7. Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties
8. Prevalence of viral pathogens in a sample of hospitalized Egyptian children with acute lower respiratory tract infections: a two-year prospective study
9. Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis
10. Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice
11. A structural-based virtual screening and in vitro validation reveals novel effective inhibitors for SARS-CoV-2 helicase and endoribonuclease.
12. Identification of potential antiviral compounds from Egyptian sea stars against MERS-CoV with the in vitro and in silico experiments
13. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
14. Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation.
15. Immunogenicity of DNA vaccine encoding spike protein against Middle East respiratory syndrome coronavirus in mammalian model
16. A structural-based virtual screening and in vitrovalidation reveals novel effective inhibitors for SARS-CoV-2 helicase and endoribonuclease
17. In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
18. Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution
19. Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line
20. Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses
21. We are underestimating, again, the true burden of H5N1 in humans
22. Chemical Profile, Antibacterial, Antibiofilm, and Antiviral Activities of Pulicaria crispa Most Potent Fraction: An In Vitro and In Silico Study
23. New potential anti-SARS-CoV-2 and anti-cancer therapies of chitosan derivatives and its nanoparticles: Preparation and characterization
24. Chapter 9 - Antiviral history and viral targets for antiviral therapy
25. Chapter 10 - Host- and genomics-based antiviral approaches
26. Chapter 2 - Viral genomics
27. Essential Oil of Cestrum diurnum L.: GC/MS Analysis, in Vitro and in Silico Anti‐HCoV‐229E Effects and Inhibitory Activity against LPS‐Induced Inflammation
28. Immunogenicity and Cross-Protective Efficacy Induced by an Inactivated Recombinant Avian Influenza A/H5N1 (Clade 2.3.4.4b) Vaccine against Co-Circulating Influenza A/H5Nx Viruses
29. Insights into targeting SARS-CoV-2: design, synthesis, in silico studies and antiviral evaluation of new dimethylxanthine derivatives
30. Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
31. Differential Impact of Specific Amino Acid Residues on the Characteristics of Avian Influenza Viruses in Mammalian Systems
32. Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies
33. Biological characterization of highly pathogenic avian influenza H5N1 viruses that infected humans in Egypt in 2014-2015
34. Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach
35. Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study
36. Assaying for antiviral activity of the folkloric medicinal desert plant Rhazya stricta on coronavirus SARS-CoV-2
37. Newly synthesized series of oxoindole–oxadiazole conjugates as potential anti-SARS-CoV-2 agents: in silico and in vitro studies
38. Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt.
39. Contributors
40. Correction: El-Shesheny et al. Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt. Pathogens 2023, 12 , 36.
41. Socializing One Health: an innovative strategy to investigate social and behavioral risks of emerging viral threats
42. In Silico and In Vivo Evaluation of SARS-CoV-2 Predicted Epitopes-Based Candidate Vaccine
43. Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies
44. Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
45. Insights into targeting SARS-CoV-2: design, synthesis, in silicostudies and antiviral evaluation of new dimethylxanthine derivativesElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00056g
46. Assaying for antiviral activity of the folkloric medicinal desert plant Rhazya strictaon coronavirus SARS-CoV-2
47. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort
48. Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
49. Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and in vitro antiviral screening
50. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.